Mortality Reduction After Oral Azithromycin Contingency: Mortality Study

NCT03338244 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

66228

Enrollment

OTHER

Sponsor class

Conditions

Childhood Mortality

Interventions

DRUG: Azithromycin
DRUG: Placebo

Sponsor

University of California, San Francisco

Collaborators

[object Object]
[object Object]